Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

X-Rays, Gamma Rays Alter Specific Small Molecules in the Blood

By Medimaging International staff writers
Posted on 06 Mar 2013
Cancer researchers have identified molecules in the bloodstream that might effectively assess the probability of radiation illness after exposure to ionizing radiation.

The animal study, led by researchers from the Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James; Columbus, USA), revealed that gamma rays or X-rays alter the levels of specific molecules called microRNA in the blood in a predictable way.

If confirmed in human subjects, the findings could lead to new technology for quickly detecting individuals at risk for acute radiation syndrome after occupational exposures or accidents such as the recent Fukushima Daiichi nuclear reactor incident. The microRNA markers might also help physicians strategize customized radiation therapy for individual patients by taking into account how different people respond to radiation treatment, the researchers reported.

The study’s findings were reported February 25, 2013, in the journal PLOS ONE. “Our paper reports the identification of a panel of microRNA markers in mice whose serum levels provide an estimate of radiation response and of the dose received after an exposure has occurred,” said senior author Dr. Arab Chakravarti, chair and professor of radiation oncology, and codirector of the Brain Tumor Program. “Accurate dose evaluation is critical for making medical decisions and for the timely administration of therapy to prevent or reduce acute and late effects.”

The findings might also one day allow clinicians to assess radiation toxicity during the course of therapy based on an individual’s biology. “This would particularly benefit leukemia and lymphoma patients who receive total body irradiation in preparation for stem-cell transplantation,” Dr. Chakravarti remarked.

First author Dr. Naduparambil Jacob, a research assistant professor in radiation oncology, noted that the study could be an important step in the development of biologic dosimetry, or biodosimetry, a technology for identifying people at risk for acute radiation illnesses that develop within weeks of radiation exposure, and cancers and degenerative diseases that can occur months or years later. “Biodosimetry is an emerging concept that could enable us to identify individuals who need immediate treatment after a radiation exposure and to better develop personalized radiation treatment plans for patients,” Dr. Jacob explained.

For this study, Drs. Chakravarti, Jacob and their colleagues evaluated dose-dependent changes in levels of 88 individual microRNAs in serum from mice after a single acute radiation exposure, and after fractionated doses of radiation that are typical of radiation treatment prior to stem-cell transplantation. Samples were collected from exposed and control animals 24 or 48 hours after exposure.

Significant findings of the study included: (1) After a one-time exposure, miRNA-150 showed a clear decrease over time with increasing radiation dose, with a drop of 30% after 24 hours and of 50% after 48 hours, even at the lowest exposure of one gray of radiation. (2) miRNA-200b and miRNA-762 showed increased levels after radiation exposure, with the changes more pronounced in animals receiving higher doses. (3) Lastly, animals receiving fractioned doses showed similar changes; e.g., miRNA-150 decreased about 50% after 24 hours in animals receiving 4 Gray.

Related Links:

Ohio State Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute



view channel

Preventing Unnecessary Breast Biopsies Using MRI

The results of a new study have shown that a new Magnetic Resonance (MR) breast imaging technique could prevent unnecessary biopsies. The new technique, called Diffusion-Weighted Imaging with Background Suppression Magnetic Resonance Mammography (DWIBS-MRM), can be used to assess the diffusion of water molecules within tissue.... Read more

Nuclear medicine

view channel
Image: The whole body of a rat can be imaged for blood clots with one PET scan, overlaid here on an MRI image, using the FBP8 probe. The arrow points to a blood clot (Photo courtesy of the American Chemical Society).

Single PET Scan Could Replace Multiple Modalities in Detecting Blood Clots

Researchers have presented an experimental technique that could be used to discover blood clots using a single, fast, whole-body scan, at the 250th National Meeting and Exposition of the American Chemical... Read more

General/Advanced Imaging

view channel

Leading Vendor to Implement and Install Enterprise Imaging Platform for UK NHS

An agreement has been announced by a leading imaging platform provider for the implementation of the first Enterprise Imaging platform, part of a long-term agreement for the management of imaging data, for the UK City Hospitals Sunderland NHS Foundation Trust. The agreement covers the capture, storage, and exchange of... Read more

Imaging IT

view channel

Carestream Updates Healthcare IT Platform

Carestream has released updates for an advanced Internet Technology (IT) healthcare platform at the Röntgenveckan Radiology congress in Malmo (Sweden). The IT platform facilitates collaboration by enabling sharing of critical patient information such as Radiology images, videos, reports, and services with groups outside... Read more

Industry News

view channel

Viztek Acquired by Konica Minolta to Complement End-to-End Healthcare IT Solutions

Konica Minolta Medical Imaging (Wayne, NJ, USA), a leading medical diagnostic primary imaging provider, has announced the completed acquisition of Viztek (Garner, NC, USA), a company providing Healthcare Internet Technology solutions. The acquisition enhances Konica Minolta’s end-to-end healthcare IT capabilities, including... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.